2% Lidocaine Plus 0.5% Bupivacaine Versus 0.5% Bupivacaine in Brachial Block for Creation of Arteriovenous (AV) Fistula

Infraclavicular Brachial Plexus Block Clinical Trial

Official title: Comparison of Onset of Action Between 2% Lidocaine Plus 0.5% Bupivacaine and 0.5% Bupivacaine in Brachial Plexus Anesthesia for Creation of Arteriovenous Fistula in ESRD Patient

Status Recruiting

Clinical Trial Summary

Will the technique of adding lidocaine to bupivacaine fasten the onset of bupivacaine alone for infraclavicular brachial plexus block in end-stage renal disease (ESRD) patient?

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Arteriovenous Fistula
• Infraclavicular Brachial Plexus Block

• NCT number: NCT00993746
• Study type: Interventional
• Source: Mahidol University
• Contact: Orawan Pongraweewan, MD,FRCA
• Phone: 6681-4317599
• Email: pongraweewan@yahoo.com
• Status: Recruiting
• Phase: Phase 4
• Start date: October 2009
• Completion date: September 2011